H. Magnussen (Grosshansdorf, Germany), T. Hansel (London, United Kingdom)
Efficacy and safety of the new beclomethasone dipropionate/formoterol combination (HFA MDI) vs. budesonide/formoterol (DPI) in moderate to severe persistent asthma
A. Papi, P. Paggiaro, J. Zarkovic, G. Nicolini, L. M. Fabbri (Ferrara, Pisa, Parma, Modena, Italy; Vienna, Austria)
|  |
Effect of particle size of dry powder mannitol on lung deposition in healthy subjects
E. Daviskas, W. Glover, H. K. Chan, S. Eberl, J. Verschuer (Sydney, Australia)
| |
Effect of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide
G. Lahu, A. Huennemeyer, F. Reutter, K. Zech, W. Wurst, R. Hermann (Konstanz, Germany)
| |
Evaluation of three devices and one technique for pulmonary drainage in a CF patient
N. H. Tiffin, S. Petras (Midlothian, United States Of America)
| |
Flow-dependent performance of several formoterol dry powder inhalers (DPIs)
M. Krummen, D. Singh, K. Fiebich, B. Haeberlin (Basel, Switzerland)
| |
Doppler echocardiographic assessment of the effects of inhaled LABAs on pulmonary artery pressure (PAP) in COPD
P. Santus, S. Centanni, A. Mantero, P. Carlucci, L. Bosotti, B. Boveri, M. Mondoni, M. Cazzola (Milan, Naples, Italy)
| |
Rapid measurement of lactate in exhaled breath condensate
M. Decker, G. Becher, G. Takam (Berlin, Germany)
| |
Body plethysmography for the assessment of long acting bronchodilators in chronic obstructive pulmonary disease
Z. L. Borrill, C. M. Houghton, R. M. Tal-Singer, R. Vessey, S. Lasenby, I. Faiferman, A. Henderson, S. J. Langley, D. Singh (Manchester, Stevenage, United Kingdom; Philadelphia, United States Of America)
| |
‘Total PDE4 inhibitory activity‘: a concept for evaluating pharmacokinetic alterations of roflumilast and roflumilast N-oxide in special populations and drug-drug interactions
R. Hermann, G. Lahu, B. Hauns, T. D. Bethke, K. Zech (Konstanz, Germany)
| |
Radioactive labeling and particle size analysis of formoterol HFA MDI Forair®
J. Gleske, H. Ehlich, P. Brand, K. Sommerer (Gauting, Germany)
| |
NVA237 has similar efficacy as tiotropium bromide against methacholine-induced bronchoconstriction and less systemic effect on cardiovascular variables in an anaesthetized rabbit model
N. Cooper, I. Walker, I. Knowles (Cambridge, London, United Kingdom)
| |
Effect of roflumilast on LPS-induced influx of inflammatory cells in lungs of healthy subjects
J. M. Hohlfeld, K. Schoenfeld, M. Lavae-Mokhtari, F. Schaumann, M. Mueller, T. D. Bethke, A. Manegold, D. Bredenbroeker, N. Krug, R. Hermann (Hannover, Konstanz, Germany)
| |
A web-based diagnostic tool for chronic cough within the community
C. E. Wright, A. H. Morice, P. Lynch (Hull, Kirk Ella, United Kingdom)
| |
Methacholine challenge test and induced sputum are useful methods for identifying the cause of chronic cough
D. Bumbacea, K. Serban, C. Teleaga, L. Cervis, A. Serbescu, M. A. Bogdan (Bucharest, Romania)
| |
Modern techniques of internasal drug use
P. Rapiejko, A. Lipiec, D. Jurkiewicz, B. Zielnik-Jurkiewicz (Warsaw, Poland)
| |
Treatment of chronic cough with morphine
R. H. Thompson, C. E. Wright, A. H. Morice (Hull, United Kingdom)
| |
Changes in cough reflex sensitivity after cessation and resumption of cigarette smoking
B. Sitkauskiene, K. Stravinskaite, R. Sakalauskas, P. V. Dicpinigaitis (Kaunas, Lithuania; Bronx, United States Of America)
| |
Antitussive activity of the herbal polysaccharides on mechanically induced cough in cats
M. Sutovska, G. Nosalova, A. Kardosova, P. Capek (Martin, Bratislava, Slovakia)
| |
How persistent is ²persistent airflow limitation² in severe asthma?
L. H. Rijssenbeek-Nouwens, A. O. Bron, C. Naves, F. Weller, E. J. Weersink, L. J. Bel (Davos, Switzerland; Amsterdam, Leiden, Netherlands)
| |
Changing respiratory parameters during dry inhalation by a jet-nebulizer using CO2-enriched ambient air
B. P. H. Wittgen, P. E. Postmus, P. W. A. Kunst (Amsterdam, Netherlands)
| |